Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients (DTIC-melvacc)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00559026
Recruitment Status : Completed
First Posted : November 16, 2007
Last Update Posted : November 16, 2007
Regina Elena Cancer Institute
University of Rome Tor Vergata
Information provided by:
Istituto Superiore di Sanità

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : September 2006